Suppr超能文献

新型抗血栓药物的研发策略:调节凝血酶的促凝血和抗凝血特性。

Strategies for development of novel antithrombotics: modulating thrombin's procoagulant and anticoagulant properties.

作者信息

Hall S W, Gibbs C S, Leung L L

机构信息

Department of Medicine, Stanford University Medical School, California 94305-5112, USA.

出版信息

Cell Mol Life Sci. 1997 Sep;53(9):731-6. doi: 10.1007/s000180050092.

Abstract

Thrombin is a serine proteinase that can interact with a large number of diverse macromolecular substrates, which results in either a procoagulant or anticoagulant effect. These divergent properties are physiologically regulated by the endogenous protein thrombomodulin. This review summarizes recent work on a variety of methods used to exploit the allosteric nature of the enzyme. The procoagulant and anticoagulant functions of thrombin can be modulated by sodium binding, site-directed mutagenesis, and a small synthetic molecule. Modulation of thrombin's intrinsic properties represents a novel approach to the development of unique antithrombotic agents.

摘要

凝血酶是一种丝氨酸蛋白酶,它可与大量不同的大分子底物相互作用,从而产生促凝血或抗凝血作用。这些不同的特性在生理上受内源性蛋白血栓调节蛋白调控。本综述总结了近期关于利用该酶变构性质的各种方法的研究工作。凝血酶的促凝血和抗凝血功能可通过钠结合、定点诱变及一种小分子合成物进行调节。对凝血酶固有特性的调节代表了一种开发独特抗血栓药物的新方法。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验